To investigate the specific mechanisms by which CDKN2B-AS1 affects the immune microenvironment and tumor progression, we first analyzed the differential expression analysis between the high- and low-CDKN2B-AS1 expressions in the TC cohort (Figures 5(b)–5(d)). Here, CDKN2B is linked to neoplasm.